Bayer AG (BAY) Determines EUR 98.98 As Cash Compensation Per Schering AG (SHR) Share
12/5/2006 10:38:16 AM
More...
|
Schering AG (SHR) And Stanford University To Cooperate In The Field Of Molecular Imaging
11/28/2006 11:37:20 AM
More...
|
Schering AG (SHR) Maintains Strong Growth Momentum During First Nine Months Of 2006
11/27/2006 10:02:29 AM
More...
|
Schering AG (SHR) Release: Betaferon(R) Approved In Australia For Earliest Stages Of Multiple Sclerosis
11/27/2006 9:24:33 AM
More...
|
Warner Chilcott Licenses Worldwide Rights To Schering AG (SHR)'s SEGRA Compound For Dermatologic Indications And Announces Settlement Of Yaz(R) Patent Litigation
11/14/2006 12:46:20 PM
More...
|
Go-Ahead For Schering AG (SHR)'s Integration Into The Bayer Group
11/8/2006 12:53:13 PM
More...
|
Entry In The Commercial Register; Agreement Between Bayer AG (BAY) And Schering AG (SHR) In Force, Resolution Of Schering Extraordinary Stockholders' Meeting Implemented
10/31/2006 11:34:00 AM
More...
|
FDA Approves Berlex Inc.'s Betaseron(R) For Use After The First Event Suggestive Of Multiple Sclerosis
10/23/2006 11:27:50 AM
More...
|
Schering AG (SHR) And Biogen Idec, Inc. (Massachusetts) (BIIB) Announce Start Of The ZEAL Phase III Clinical Trial With Anti-Cancer Drug Zevalin
10/5/2006 10:51:55 AM
More...
|
FDA Approves New Indication For Berlex Inc.'s YAZ(R) To Treat Emotional And Physical Symptoms Of Premenstrual Dysphoric Disorder (PMDD)
10/5/2006 9:25:05 AM
More...
|
|